Finally, since there are some inclusion and exclusion criteria of LC patients with PD-1/PD-L1 inhibitors, some patients have not been allowed to be included in our study, the validation cohort is needed in the future study. The gene discussed is CD274; the disease is laryngotracheoesophageal cleft.